Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa2g01113 ATGTCTGAAACCTTAAGGAATCTCTCACTTTCTCCCAAAAACTTCTCCTTCACCTTCACCTTGTTTCTCTTATTAAACTCTTTTCTTCTCATTCCGTTTTGTTACTCTTATTCACTCAATGAACAAGGACAAGCTCTTGTAGCATGGAAAAACAGTTTAAACAATACTTTAGAATCTGTAGATGCATTATCATCATGGAACTCTTTAGCCACAACACCATGCAACAACTGGTTTGGAGTGTATTGCAATCCACAAGGAGATGTGGTAGAGATAAACTTGAAATCATTGCGTTTACAAGGCGAGTTGCCTTCGAATTTTCAACCTCTAAAGTCCTTGAAGAGACTCATCCTCTCATCAACAAACATCACTGGAAGGATACCGAAAGAGATTGGAGATTATCACGAGCTCGCTGTCATTGATCTAAGTGGAAACTCTTTGGTTGGTGAAATACCAGAAGAAATCTGCAGGCTAAGCAAACTTGAGAGTTTGTTTCTTCATACAAATTTCTTCGAAGGAGACATTCCGTCCGACATTGGAAATCTAACTAGTCTTGTGAACTTTACACTCTATGATAATCATTTGAGTGGCGAAATTCCAAAGAGTGTTGGTTTGTTGAACAAGCTTCAAGTGTTTAGAGCTGGTGGCAATAAGAATCTCAAAGGCGAGATTCCTTTCGAGATTGGAAACTGCACAAACTTGATCCTATTAGGCCTTGCAGAAACAAGTATTTCCGGAAGCATTCCTTCTTCGATCCAAATGTTGAAAAGAATCAGAACTATAGCCATTTACACAACTCTCTTATCAGGCTCAATTCCACAAGAGATTGGAAATTGCAGTGAGTTGCAGAATCTTTACTTGTATCAGAATTCTCTCTCAGGTTCAATTCCAGCTCAAATTGGAGAACTCAACAATTTAAAGAGCCTACTCTTATGGCAGAACAATTTAGTTGGTACTATTCCAGAAGAGCTTGGAAGGTGCAAAGAGATTCAAGTCATTGACTTTTCAGAAAATCTTTTAACAGGTAGCATACCCAAGATTCTTGGCGAGCTTTCAAATCTTCAAGAGCTTCAACTGAGTGTGAATCATCTCTCAGGTATCATACCTGCCGAGATTTCAAATTGTGTTTCCTTGACTCAACTTGAACTTGACAACAATGCTTTATCTGGTGAGATTCCTCCTCTTATTGGCAACTTGAGAAGCTTGAATTTGTTCTTTGCATGGCAGAACAAGTTGACAGGAAAAATTCCAGATAGTCTTTCAGATTGTCAAGAACTTCAATCACTCGACCTTTCTTACAATGATTTGTTCGGTACAATACCAAAAACACTCTTTAATTTGAGGAACCTCACAAAACTTTTGCTTATTTCCAATGCTTTATCAGGCTTTATACCTCCTGATATAGGAAACTGCACAAACCTCTACAGACTTAGACTGAATCACAATAGAATATCAGGTAACATTCCGAATGAGATTGGTAACTTGAATAGTTTGAATTTTGTGGATATAAGTGACAATCATTTAGTAGGTGAGATTCCTCCAACACTTTCTAGATGTCAAAATCTCGAGTTTCTAGACTTTCATTCAAATAGTCTTACCGGTTCCATTCCAGATTCTCTTCCTAAAAGCCTACAATTGATTGATTTGTCGGACAATAGTCTATCAGGTGAATTGAGTCATACCATTGGTTCGTTAGTCGAGTTAAGCAAACTAAACTTAGGAAAGAATCAATTAATTGGAAGAATCCCATCAGAGATTTTGTCTTGTACTAAGCTACAGCTTCTAGACCTTGGAAGCAACAGTTTCACTGGAGAAATTCCCAAGGAATTGAGTCTTATTCCTTCATTAGAAATCTCTCTTAATCTCAGTTTCAACCATTTTTCGGGTGAAATACCTTCACAATTCTCGAGTCTTGGAAAACTAGGAGTGCTTGATCTCTCACATAACAATCTCTCAGGGAATTTAGATTCTCTCTCCAACCTTGAAAATCTTGTTTTGTTAAATGTTTCCTTCAATGCCTTCTCTGGTAAGTTACCTAACACACCTTTCTTTCGTAAACTTCCTCTCAGTGATCTTGCTGAAAACAAAGGTCTTTACATTGCTGGAGATGTTACAACTTCTGCTGATAGAACGGAATCCAAAGGTCATGCAAAACCAGTTATGAAATCTGTAATGTCGATTCTATTAAGCACGAGTGCAGTCGTAGTTCTGCTCACAGTCTATGTCTTGATTCGTTCGCACATAGCAGAAAAATCACTCATGGAAAATGAAAGTTGGGAGGTGACTTTGTATCAAAAATTCGATCTCTCCATTGATGACATTGTCTTGAATCTGACATCGTCCAATGTGATTGGCACCGGAAGTTCAGGAGTTGTGTACAAGGTAATAATTCCAAACGGAGAAACACTTGCAGTTAAAAAGATGTGGTCATCAGAAGAATCGGGGGCATTCAATTCCGAAATTCAAACGTTAGGTTCAATCAGACACAAGAATATCATTAGGCTTCTCGGTTGGGGATCCAACAGGAATCTGAAGCTTCTGTTTTACGACTATCTTCCCAACGGAAGCCTTAGCTCGTTACTTCATGGTTCAGGAAAGGGAAAAGCGGAATGGGAAACAAGATATGATGTTGTATTAGGTGTGGCTCATGCACTTGCATATTTGCACCATGATTGTGTTCCTGCAATAATGCATGGAGATGTCAAAGCCATGAATGTTTTATTAGGTCCAAGCTATCAACCTTACCTCGCCGACTTTGGCTTAGCAAGAATCGCAACCGAAAATGATGATAATACTAATTCCAAGCCAGTTCAAAGACATTACCTTGCTGGTTCATATGGATACATGGCTCCTGAACATGCATCAATGCAGCCTATAACTGAGAAAAGTGATGTTTACAGTTATGGAATGGTTCTACTTGAGGTCTTAACAGGAAGGCACCCTTTAGATCCAACTCTTCCGGGAGGCGCAAACATGGTCCAATGGGTTAGGAATCATTTATCTAACAAAGGCGATCCTTCTGAGATTCTCGATACAAAGCTTAGAGGAAGGGCTGATCATACCATGCATGAAATGCTACAAACTTTAGCAGTGTCATTTCTCTGTGTAAGCACAAGAGCGGTTGACCGTCCAGCAATGAAAGACGTCGTCGCAATGCTCAAAGAAATTAAACCTGTAGAGACATCAAGATCAGACACTGATGTATTGAAACTAGGAGGCTTAACATCATCTCATAATTCTCCACCACCTCCAAAGAATGTACTTTCGCATGGATCTTCTACTTGTTCCTATAATTTCTCGGACGGTTGA 3306 0.3905 MSETLRNLSLSPKNFSFTFTLFLLLNSFLLIPFCYSYSLNEQGQALVAWKNSLNNTLESVDALSSWNSLATTPCNNWFGVYCNPQGDVVEINLKSLRLQGELPSNFQPLKSLKRLILSSTNITGRIPKEIGDYHELAVIDLSGNSLVGEIPEEICRLSKLESLFLHTNFFEGDIPSDIGNLTSLVNFTLYDNHLSGEIPKSVGLLNKLQVFRAGGNKNLKGEIPFEIGNCTNLILLGLAETSISGSIPSSIQMLKRIRTIAIYTTLLSGSIPQEIGNCSELQNLYLYQNSLSGSIPAQIGELNNLKSLLLWQNNLVGTIPEELGRCKEIQVIDFSENLLTGSIPKILGELSNLQELQLSVNHLSGIIPAEISNCVSLTQLELDNNALSGEIPPLIGNLRSLNLFFAWQNKLTGKIPDSLSDCQELQSLDLSYNDLFGTIPKTLFNLRNLTKLLLISNALSGFIPPDIGNCTNLYRLRLNHNRISGNIPNEIGNLNSLNFVDISDNHLVGEIPPTLSRCQNLEFLDFHSNSLTGSIPDSLPKSLQLIDLSDNSLSGELSHTIGSLVELSKLNLGKNQLIGRIPSEILSCTKLQLLDLGSNSFTGEIPKELSLIPSLEISLNLSFNHFSGEIPSQFSSLGKLGVLDLSHNNLSGNLDSLSNLENLVLLNVSFNAFSGKLPNTPFFRKLPLSDLAENKGLYIAGDVTTSADRTESKGHAKPVMKSVMSILLSTSAVVVLLTVYVLIRSHIAEKSLMENESWEVTLYQKFDLSIDDIVLNLTSSNVIGTGSSGVVYKVIIPNGETLAVKKMWSSEESGAFNSEIQTLGSIRHKNIIRLLGWGSNRNLKLLFYDYLPNGSLSSLLHGSGKGKAEWETRYDVVLGVAHALAYLHHDCVPAIMHGDVKAMNVLLGPSYQPYLADFGLARIATENDDNTNSKPVQRHYLAGSYGYMAPEHASMQPITEKSDVYSYGMVLLEVLTGRHPLDPTLPGGANMVQWVRNHLSNKGDPSEILDTKLRGRADHTMHEMLQTLAVSFLCVSTRAVDRPAMKDVVAMLKEIKPVETSRSDTDVLKLGGLTSSHNSPPPPKNVLSHGSSTCSYNFSDG 1101
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vifa2g01113 1101 SUPERFAMILY L domain-like 48 316 - -
Vifa2g01113 1101 Pfam Protein kinase domain 780 982 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g01113 1101 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE FAMILY PROTEIN-RELATED 313 1052 - -
Vifa2g01113 1101 ProSiteProfiles Protein kinase domain profile. 777 1055 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g01113 1101 Pfam Leucine rich repeat N-terminal domain 40 83 IPR013210 -
Vifa2g01113 1101 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 746 850 - -
Vifa2g01113 1101 FunFam Leucine-rich receptor-like protein kinase family protein 345 617 - -
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 343 438 IPR032675 -
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 158 245 IPR032675 -
Vifa2g01113 1101 Gene3D Transferase(Phosphotransferase) domain 1 851 1070 - -
Vifa2g01113 1101 MobiDBLite consensus disorder prediction 1068 1101 - -
Vifa2g01113 1101 SMART LRR_typ_2 637 660 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 302 326 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 564 588 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 109 133 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 494 518 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 350 374 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 446 470 IPR003591 -
Vifa2g01113 1101 SMART LRR_typ_2 157 181 IPR003591 -
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 439 540 IPR032675 -
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 618 703 IPR032675 -
Vifa2g01113 1101 SMART serkin_6 777 1050 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 41 155 IPR032675 -
Vifa2g01113 1101 ProSiteProfiles Leucine-rich repeat profile. 639 661 IPR001611 GO:0005515
Vifa2g01113 1101 FunFam LRR receptor-like serine/threonine-protein kinase RCH1 851 1070 - -
Vifa2g01113 1101 FunFam LRR receptor-like serine/threonine-protein kinase RCH1 217 342 - -
Vifa2g01113 1101 Gene3D Phosphorylase Kinase; domain 1 741 850 - -
Vifa2g01113 1101 ProSitePatterns Serine/Threonine protein kinases active-site signature. 895 907 IPR008271 GO:0004672|GO:0006468
Vifa2g01113 1101 ProSitePatterns Protein kinases ATP-binding region signature. 783 806 IPR017441 GO:0005524
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 246 342 IPR032675 -
Vifa2g01113 1101 Gene3D Ribonuclease Inhibitor 541 617 IPR032675 -
Vifa2g01113 1101 FunFam Leucine-rich receptor-like protein kinase family protein 39 204 - -
Vifa2g01113 1101 SUPERFAMILY RNI-like 295 662 - -
Vifa2g01113 1101 Pfam Leucine rich repeat 330 387 IPR001611 GO:0005515
Vifa2g01113 1101 Pfam Leucine Rich Repeat 425 446 IPR001611 GO:0005515
Vifa2g01113 1101 SUPERFAMILY Protein kinase-like (PK-like) 775 1052 IPR011009 -
Vifa2g01113 1101 FunFam Putative LRR receptor-like serine/threonine-protein kinase 618 703 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vifa2g01113 Vifa-Chr2 301570096 301573580 Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa2g01113 37 1100 Receptor kinase-like Gene Family AT5G56040 65.733 0.0 1387
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XI-1 Vifa2g01113 Pkinase 1.1e-37 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa2g01113 - - psat:127084696 1992.62